Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders

Saved in:

Bibliographic Details
Published in	Neuropsychopharmacology (New York, N.Y.) Vol. 45; no. 1; pp. 234 - 235
Main Authors	Bhattacharya, Anindya, Ceusters, Marc
Format	Journal Article
Language	English
Published	England Nature Publishing Group 01.01.2020 Springer International Publishing
Subjects	Addictions Alzheimer's disease Animals Antagonists Binding sites Brain - diagnostic imaging Brain - drug effects Brain - metabolism Brain research Cocaine Comorbidity Dosimetry Drug Delivery Systems - methods Drug dosages Hot Topics Human subjects Humans Inflammation Inflammation - diagnostic imaging Inflammation - drug therapy Inflammation - metabolism Laboratories Ligands Mental disorders Mental Disorders - diagnostic imaging Mental Disorders - drug therapy Mental Disorders - metabolism Narcotics Nervous System Diseases - diagnostic imaging Nervous System Diseases - drug therapy Nervous System Diseases - metabolism Neurosciences Psychosis Purinergic P2X Receptor Antagonists - administration & dosage Purinergic P2X Receptor Antagonists - metabolism R&D Research & development
Online Access	Get full text
ISSN	0893-133X 1740-634X 1740-634X
DOI	10.1038/s41386-019-0502-9

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-News-1 content type line 23
ISSN:	0893-133X 1740-634X 1740-634X
DOI:	10.1038/s41386-019-0502-9